Novartis AG vs Rivian Automotive, Inc. — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while Rivian Automotive, Inc. trades at $16.42 (market cap $23.69B). The key difference: Novartis AG is far larger — about 12.5× Rivian Automotive, Inc.'s market cap, and Novartis AG pays a 3.07% dividend while Rivian Automotive, Inc. pays none. Which is the better fit depends on your goals.
| NVS | RIVN | |
|---|---|---|
Market Cap | $295.37B | $23.69B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $22.45 |
52-Week Low | $119.31 | $11.97 |
Enterprise Value | $336.69B | $23.73B |
Dividend Yield | 3.07% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →